| Home | About Us | Advisory Boards | Products | Pipeline | Investor Centre | Partnering | Contact Us |
ASX Code: ACL |
Trial of with HA-Irinotecan vs Irinotecan in metastatic colorectal cancer (mCRC) patientsLatest News
Annual Report
Click here to view Alchemia's
2011 Annual Report
Email Alerts
Keep up to date with the latest Alchemia news.
Click here to subscribe to our free email alerts service.
Webcasts
| Copyright © Alchemia Limited | Privacy | Disclaimer | Site Map | Search | Glossary |